| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |